PO-0835: Contact Radiotherapy For Lentigo Maligna And Lentigo Maligna Melanoma: A Cohort Of 61 Cases
A. Lamoureux(Hôpital Saint Eloi), V. Vendrely(Centre Hospitalier Universitaire de Bordeaux), R. Trouette(Centre Hospitalier Universitaire de Bordeaux), A. Pham-Ledard, Caroline Dutriaux(Centre Hospitalier Universitaire de Bordeaux), O. Cogrel(Centre Hospitalier Universitaire de Bordeaux), N. Ouhabrache, E. Gérard(Université de Bordeaux), M. Beylot‐Barry(Université de Bordeaux), L. Dousset(Centre Hospitalier Universitaire de Bordeaux), S. Coulibaly
Cited by 2
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
|New England Journal of Medicine|2017|1.5k